It is well established that histoplasmosis is an opportunistic and overwhelming disease in patients with very low CD4 counts, and, therefore, we believe that screening is necessary and desirable in immunosuppressed patients, particularly those with CD4+ < 100, for both cryptococcosis and histoplasmosis, the most important systemic mycoses in HIV/AIDS. The gene discussed is CD4; the disease is fungal infectious disease.